75 results
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
) – Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory … and delivering innovative, transformative, precision diagnostics and clinical laboratory services. Avalon is establishing a leading role
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
21 Aug 23
Avalon’s Laboratory Services MSO Announces Expansion into Arizona
9:11am
., August 21, 2023 (GLOBE NEWSWIRE) – Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics … and delivering innovative, transformative, precision diagnostics and clinical laboratory services. Avalon is establishing a leading role in the innovation
8-K
EX-99.1
pu6b wdud
24 Jul 23
Avalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth
9:05am
8-K
EX-99.1
nlkgs mtrtt
19 Jul 23
Regulation FD Disclosure
9:21am
424B3
fk4coyng6jd32757
29 Jun 23
Prospectus supplement
4:31pm
8-K
EX-99.1
bi3c52vrl6dho82m vj
16 Jun 23
Entry into a Material Definitive Agreement
4:08pm
8-K
zv5ot69
16 Jun 23
Entry into a Material Definitive Agreement
4:08pm
8-K
EX-99.1
uxw3lfgdhiz
27 Apr 23
Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022
4:26pm
8-K
EX-99.1
ss7azud
14 Dec 22
Entry into a Material Definitive Agreement
9:18am
DEFA14A
3gkh9g73lfzir
12 Dec 22
Additional proxy soliciting materials
10:41am
8-K
EX-99.1
xs9fdgei3sd7frbp5fk
8 Nov 22
Entry into a Material Definitive Agreement
9:15am